Cargando…
Biology, vulnerabilities and clinical applications of circulating tumour cells
In recent years, exceptional technological advances have enabled the identification and interrogation of rare circulating tumour cells (CTCs) from blood samples of patients, leading to new fields of research and fostering the promise for paradigm-changing, liquid biopsy-based clinical applications....
Autores principales: | Ring, Alexander, Nguyen-Sträuli, Bich Doan, Wicki, Andreas, Aceto, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734934/ https://www.ncbi.nlm.nih.gov/pubmed/36494603 http://dx.doi.org/10.1038/s41568-022-00536-4 |
Ejemplares similares
-
Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer
por: Ring, Alexander, et al.
Publicado: (2022) -
“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”
por: Höller, Anna, et al.
Publicado: (2023) -
MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies
por: Schwab, Fabienne D., et al.
Publicado: (2022) -
Recent advances in the biology of human circulating tumour cells and metastasis
por: Gkountela, Sofia, et al.
Publicado: (2016) -
Circulating tumour cells in gastrointestinal cancers: food for thought?
por: Asawa, Simran, et al.
Publicado: (2023)